Mucosal immunity and nasal influenza vaccination (Q38028996)

27 August 2017

title

Mucosal immunity and nasal influenza vaccination (English)

1 reference

27 August 2017

Markus A Rose

1 reference

27 August 2017

Stefan Zielen

series ordinal

1 reference

27 August 2017

Ulrich Baumann

series ordinal

1 reference

27 August 2017

publication date

1 May 2012

1 reference

Expert Review of Vaccines

27 August 2017

published in

1 reference

27 August 2017

1 reference

27 August 2017

1 reference

27 August 2017

page(s)

595-607

1 reference

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children

27 August 2017

cites work

1 reference

Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract

21 January 2018

1 reference

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus

21 January 2018

1 reference

The biology of intestinal immunoglobulin A responses

21 January 2018

1 reference

Fcgamma receptors: old friends and new family members

21 January 2018

1 reference

Immunological commonalities and distinctions between airway and digestive immunity

21 January 2018

1 reference

Induction of secretory immunity and memory at mucosal surfaces

21 January 2018

1 reference

Regional specialization in the mucosal immune system: primed cells do not always home along the same track

21 January 2018

1 reference

Intestinal lamina propria dendritic cell subsets have different origin and functions.

21 January 2018

1 reference

Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans.

21 January 2018

1 reference

NALT- versus Peyer's-patch-mediated mucosal immunity

21 January 2018

1 reference

Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: a clinical trial of immunogenicity in lower airways of human volunteers

21 January 2018

1 reference

Physiology of IgA and IgA deficiency

21 January 2018

1 reference

The immune geography of IgA induction and function

21 January 2018

1 reference

Differentiation and homing of IgA-secreting cells

21 January 2018

1 reference

Mucosal immunization of CD4+ T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions

21 January 2018

1 reference

Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut

21 January 2018

1 reference

In situ class switching and differentiation to IgA-producing cells in the gut lamina propria

21 January 2018

1 reference

T cell independent antigens

21 January 2018

1 reference

Basophils and the T helper 2 environment can promote the development of lupus nephritis

21 January 2018

1 reference

New insights into the enigma of immunoglobulin D.

21 January 2018

1 reference

The B-cell system of human mucosae and exocrine glands

21 January 2018

1 reference

Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation

21 January 2018

1 reference

Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut

21 January 2018

1 reference

Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method

21 January 2018

1 reference

Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus

21 January 2018

1 reference

The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA

21 January 2018

1 reference

Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia.

21 January 2018

1 reference

Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study

21 January 2018

1 reference

Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice

21 January 2018

1 reference

Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines

21 January 2018

1 reference

High prevalence of influenza specific antibody secreting cells in nasal mucosa

21 January 2018

1 reference

Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils

21 January 2018

1 reference

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines

21 January 2018

1 reference

Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

21 January 2018

1 reference

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

21 January 2018

1 reference

Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children

21 January 2018

1 reference

A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older

21 January 2018

1 reference

Influence of prior influenza vaccination on antibody and B-cell responses

21 January 2018

1 reference

Nasal lavage natural killer cell function is suppressed in smokers after live attenuated influenza virus

21 January 2018

1 reference

Mucosal vaccination against bacterial respiratory infections

21 January 2018

1 reference

A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults

21 January 2018

1 reference

Innate signaling and regulation of Dendritic cell immunity

21 January 2018

1 reference

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

21 January 2018

1 reference

Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults

21 January 2018

1 reference

Chitosan as a novel nasal delivery system for vaccines

21 January 2018

1 reference

Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives

21 January 2018

1 reference

Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans

21 January 2018

1 reference

Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine

21 January 2018

1 reference

New adjuvants for human vaccines

21 January 2018

1 reference

Symbiotic bacteria direct expression of an intestinal bactericidal lectin

21 January 2018

1 reference

TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation

21 January 2018

1 reference

Adjuvants and autoimmunity

21 January 2018

1 reference

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

21 January 2018

1 reference

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

21 January 2018

1 reference

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis

21 January 2018

1 reference

Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity

21 January 2018

1 reference

Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy

21 January 2018

1 reference

Drug delivery to the nasal cavity: in vitro and in vivo assessment

21 January 2018

1 reference

Noninvasive delivery technologies: respiratory delivery of vaccines

21 January 2018

1 reference

Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants

21 January 2018

1 reference

Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine

21 January 2018

1 reference

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia

21 January 2018

1 reference

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.

21 January 2018

1 reference

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma

21 January 2018

1 reference

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

21 January 2018

1 reference

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

21 January 2018

1 reference

A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years

21 January 2018

1 reference

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

21 January 2018

1 reference

The Japanese experience with vaccinating schoolchildren against influenza

21 January 2018

1 reference

Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model

21 January 2018

1 reference

Intestinal Bacteria Trigger T Cell-Independent Immunoglobulin A2 Class Switching by Inducing Epithelial-Cell Secretion of the Cytokine APRIL

21 January 2018

1 reference

Mucosal penetrability enhanced by serum-derived antibodies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.31

1 reference

27 August 2017

1 reference